• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    Cortex Pharmaceuticals, Inc. (CORX)

    -Other OTC
    0.06 Down 0.00(1.43%) 3:45PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Cortex Pharmaceuticals, Inc.
    126 Valley Road
    Suite C
    Glen Rock, NJ 07452
    United States - Map
    Phone: 201-906-2467
    Website: http://www.cortexpharm.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:1

    Business Summary 

    Cortex Pharmaceuticals, Inc. engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. The company is also involved in clinical development in the areas of neurological and psychiatric disorders. It develops ampakine compounds comprising CX1739 for the treatment of patients with central and mixed sleep apnea; and CX1942, a soluble ampakine, to be used in an injectable formulation as a rescue medication for the emergency treatment of drug-induced respiratory depression. The company was founded in 1987 and is headquartered in Glen Rock, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cortex Pharmaceuticals, Inc.

    Key Executives 
    Dr. Arnold S. Lippa Ph.D., 68
    Exec. Chairman, Chief Exec. Officer and Pres
    Mr. Robert Neal Weingarten , 63
    Chief Financial Officer, VP and Director
    Mr. Jeff Eliot Margolis , 59
    VP, Treasurer, Sec. and Director
    Dr. Gary S. Lynch Ph.D., 72
    Co-Founder, Scientific Director and Consultant
    Dr. Leslie J. Street Ph.D., 56
    Sr. Director of Medicinal Chemistry
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders